vs
LifeStance Health Group, Inc.（LFST）与null（SDHC）财务数据对比。点击上方公司名可切换其他公司
LifeStance Health Group, Inc.的季度营收约是null的1.5倍（$382.2M vs $260.4M），LifeStance Health Group, Inc.净利率更高（3.1% vs 1.4%，领先1.7%），LifeStance Health Group, Inc.同比增速更快（17.4% vs -9.4%），LifeStance Health Group, Inc.自由现金流更多（$46.6M vs $8.7M），过去两年null的营收复合增速更高（17.3% vs 12.8%）
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
史密斯韦森品牌公司是美国的枪械制造商，总部位于美国田纳西州玛丽维尔，是该领域历史悠久且知名的生产企业，在民用及警用枪械市场拥有较高的认可度。
LFST vs SDHC — 直观对比
营收规模更大
LFST
是对方的1.5倍
$260.4M
营收增速更快
LFST
高出26.8%
-9.4%
净利率更高
LFST
高出1.7%
1.4%
自由现金流更多
LFST
多$37.9M
$8.7M
两年增速更快
SDHC
近两年复合增速
12.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $382.2M | $260.4M |
| 净利润 | $11.7M | $3.5M |
| 毛利率 | — | 19.9% |
| 营业利润率 | 4.7% | 6.5% |
| 净利率 | 3.1% | 1.4% |
| 营收同比 | 17.4% | -9.4% |
| 净利润同比 | 264.1% | -14.3% |
| 每股收益（稀释后） | — | $0.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LFSTSDHC
| Q4 25 | $382.2M | $260.4M | ||
| Q3 25 | $363.8M | $262.0M | ||
| Q2 25 | $345.3M | $223.9M | ||
| Q1 25 | $333.0M | $224.7M | ||
| Q4 24 | $325.5M | $287.5M | ||
| Q3 24 | $312.7M | $277.8M | ||
| Q2 24 | $312.3M | $220.9M | ||
| Q1 24 | $300.4M | $189.2M |
净利润LFSTSDHC
| Q4 25 | $11.7M | $3.5M | ||
| Q3 25 | $1.1M | $2.1M | ||
| Q2 25 | $-3.8M | $2.4M | ||
| Q1 25 | $709.0K | $2.7M | ||
| Q4 24 | $-7.1M | $4.1M | ||
| Q3 24 | $-6.0M | $5.3M | ||
| Q2 24 | $-23.3M | $3.6M | ||
| Q1 24 | $-21.1M | $3.0M |
毛利率LFSTSDHC
| Q4 25 | — | 19.9% | ||
| Q3 25 | — | 21.0% | ||
| Q2 25 | — | 23.2% | ||
| Q1 25 | — | 23.8% | ||
| Q4 24 | — | 25.5% | ||
| Q3 24 | — | 26.5% | ||
| Q2 24 | — | 26.7% | ||
| Q1 24 | — | 26.1% |
营业利润率LFSTSDHC
| Q4 25 | 4.7% | 6.5% | ||
| Q3 25 | 2.0% | 6.6% | ||
| Q2 25 | -0.9% | 7.7% | ||
| Q1 25 | 0.5% | 8.7% | ||
| Q4 24 | 0.3% | 10.4% | ||
| Q3 24 | 0.0% | 14.2% | ||
| Q2 24 | -5.1% | 11.7% | ||
| Q1 24 | -5.6% | 11.3% |
净利率LFSTSDHC
| Q4 25 | 3.1% | 1.4% | ||
| Q3 25 | 0.3% | 0.8% | ||
| Q2 25 | -1.1% | 1.1% | ||
| Q1 25 | 0.2% | 1.2% | ||
| Q4 24 | -2.2% | 1.4% | ||
| Q3 24 | -1.9% | 1.9% | ||
| Q2 24 | -7.5% | 1.7% | ||
| Q1 24 | -7.0% | 1.6% |
每股收益（稀释后）LFSTSDHC
| Q4 25 | — | $0.39 | ||
| Q3 25 | — | $0.24 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | — | $0.30 | ||
| Q4 24 | — | $0.50 | ||
| Q3 24 | — | $0.58 | ||
| Q2 24 | — | $0.40 | ||
| Q1 24 | — | $0.33 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $248.6M | $12.7M |
| 总债务越低越好 | $282.8M | — |
| 股东权益账面价值 | $1.5B | $86.7M |
| 总资产 | $2.2B | $557.6M |
| 负债/权益比越低杠杆越低 | 0.19× | — |
8季度趋势，按日历期对齐
现金及短期投资LFSTSDHC
| Q4 25 | $248.6M | $12.7M | ||
| Q3 25 | $203.9M | $14.8M | ||
| Q2 25 | $188.9M | $16.8M | ||
| Q1 25 | $134.3M | $12.7M | ||
| Q4 24 | $154.6M | $22.4M | ||
| Q3 24 | $102.6M | $23.7M | ||
| Q2 24 | $87.0M | $17.3M | ||
| Q1 24 | $49.5M | $32.8M |
总债务LFSTSDHC
| Q4 25 | $282.8M | — | ||
| Q3 25 | $284.6M | — | ||
| Q2 25 | $286.4M | — | ||
| Q1 25 | $288.2M | — | ||
| Q4 24 | $290.0M | — | ||
| Q3 24 | $287.3M | — | ||
| Q2 24 | $288.0M | — | ||
| Q1 24 | $288.8M | — |
股东权益LFSTSDHC
| Q4 25 | $1.5B | $86.7M | ||
| Q3 25 | $1.5B | $82.2M | ||
| Q2 25 | $1.5B | $80.0M | ||
| Q1 25 | $1.5B | $76.9M | ||
| Q4 24 | $1.4B | $73.6M | ||
| Q3 24 | $1.4B | $68.4M | ||
| Q2 24 | $1.4B | $62.1M | ||
| Q1 24 | $1.4B | $59.7M |
总资产LFSTSDHC
| Q4 25 | $2.2B | $557.6M | ||
| Q3 25 | $2.1B | $571.6M | ||
| Q2 25 | $2.1B | $570.2M | ||
| Q1 25 | $2.1B | $513.9M | ||
| Q4 24 | $2.1B | $475.9M | ||
| Q3 24 | $2.1B | $460.1M | ||
| Q2 24 | $2.1B | $429.3M | ||
| Q1 24 | $2.1B | $401.3M |
负债/权益比LFSTSDHC
| Q4 25 | 0.19× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | 0.20× | — | ||
| Q4 24 | 0.20× | — | ||
| Q3 24 | 0.20× | — | ||
| Q2 24 | 0.20× | — | ||
| Q1 24 | 0.20× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.6M | $9.8M |
| 自由现金流经营现金流 - 资本支出 | $46.6M | $8.7M |
| 自由现金流率自由现金流/营收 | 12.2% | 3.4% |
| 资本支出强度资本支出/营收 | 2.9% | 0.4% |
| 现金转化率经营现金流/净利润 | 4.93× | 2.77× |
| 过去12个月自由现金流最近4个季度 | $110.0M | $-36.9M |
8季度趋势，按日历期对齐
经营现金流LFSTSDHC
| Q4 25 | $57.6M | $9.8M | ||
| Q3 25 | $27.3M | $22.8M | ||
| Q2 25 | $64.4M | $-28.9M | ||
| Q1 25 | $-3.1M | $-34.9M | ||
| Q4 24 | $62.3M | $5.5M | ||
| Q3 24 | $22.7M | $22.9M | ||
| Q2 24 | $44.1M | $39.0K | ||
| Q1 24 | $-21.8M | $-9.3M |
自由现金流LFSTSDHC
| Q4 25 | $46.6M | $8.7M | ||
| Q3 25 | $17.0M | $21.4M | ||
| Q2 25 | $56.6M | $-31.1M | ||
| Q1 25 | $-10.3M | $-35.9M | ||
| Q4 24 | $56.0M | $4.8M | ||
| Q3 24 | $17.7M | $22.3M | ||
| Q2 24 | $39.0M | $-2.1M | ||
| Q1 24 | $-26.9M | $-9.7M |
自由现金流率LFSTSDHC
| Q4 25 | 12.2% | 3.4% | ||
| Q3 25 | 4.7% | 8.2% | ||
| Q2 25 | 16.4% | -13.9% | ||
| Q1 25 | -3.1% | -16.0% | ||
| Q4 24 | 17.2% | 1.7% | ||
| Q3 24 | 5.7% | 8.0% | ||
| Q2 24 | 12.5% | -1.0% | ||
| Q1 24 | -9.0% | -5.1% |
资本支出强度LFSTSDHC
| Q4 25 | 2.9% | 0.4% | ||
| Q3 25 | 2.8% | 0.5% | ||
| Q2 25 | 2.2% | 0.9% | ||
| Q1 25 | 2.2% | 0.5% | ||
| Q4 24 | 1.9% | 0.2% | ||
| Q3 24 | 1.6% | 0.2% | ||
| Q2 24 | 1.6% | 1.0% | ||
| Q1 24 | 1.7% | 0.2% |
现金转化率LFSTSDHC
| Q4 25 | 4.93× | 2.77× | ||
| Q3 25 | 25.34× | 10.70× | ||
| Q2 25 | — | -12.24× | ||
| Q1 25 | -4.36× | -13.01× | ||
| Q4 24 | — | 1.33× | ||
| Q3 24 | — | 4.28× | ||
| Q2 24 | — | 0.01× | ||
| Q1 24 | — | -3.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LFST
暂无分部数据
SDHC
| Southeast | $164.7M | 63% |
| Central | $95.8M | 37% |
